24/7 Field Service Engineer Hotline: +1-800-783-7477 UDI Look-up · GPO Contracts: Premier · Vizient · HealthTrust
Steris Clinical Article

A side-by-side comparison of two infection control procurement approaches—built-in device design vs. added-on protocols—across total cost, operational efficiency, and compliance consistency, with scenario-specific selection guidance.

Mikkel Sorensen

A side-by-side comparison of two infection control procurement approaches—built-in device design vs. added-on protocols—across total cost, operational efficiency, and compliance consistency, with scenario-specific selection guidance.

Clinical equipment planning desk

What Is Infection Control, and Why Your Procurement Approach Matters

Infection control is the practice of preventing healthcare-associated infections through device design, sterilization protocols, staff behavior, and environmental management. It's not a single product you buy—it's a system you enter into. And in procurement, you're choosing between two fundamentally different systems.

I'm a quality and compliance manager at a medical device procurement firm. I review every device and supplier spec before it reaches our clinical customers—roughly 180 items annually. I rejected 12% of first submissions in 2024 due to incomplete infection-control documentation. So this comparison isn't theoretical for me. It's Tuesday.

Here's the framework: on one side, devices with built-in infection control design—closed systems, single-use components, automated disinfection cycles. On the other, added-on protocols—reusable devices managed through staff procedure, manual cleaning, and process compliance.

The three dimensions I'll compare: total cost, operational efficiency, and compliance consistency. One of these produced a result I didn't expect. Let's get into it.

Dimension 1: Total Cost — Upfront Premium vs. Lifecycle Reality

The conventional wisdom says built-in design costs more upfront and pays off later. That's partly true. But the lifecycle math has a twist most procurement teams don't see until they've already signed the PO.

Take a Smiths Medical syringe pump with a closed medication delivery system. The per-unit price is typically 15–20% higher than a comparable open-system pump. That's a real budget hit—I'm not going to pretend it isn't. But the hidden costs of the open system don't show up on the purchase order: line contamination risk, additional disinfection steps between patients, and the labor to manage both.

When I ran the numbers for our 2024 syringe pump tender, the closed system's total cost over 3 years came out 11% lower. Not because the device was cheaper—it wasn't—but because the added-on protocol required 6 more minutes of nursing time per shift. Across a 40-bed unit, that's roughly 146 hours annually. At $38/hour loaded labor, that's $5,548 per unit in avoided hidden cost. Multiply by 14 units and the math stops being subtle.

Here's where my expectation flipped: for incontinence products, the calculus reverses. Disposable products have a higher per-use cost than reusable alternatives. But in low-volume settings—under about 50 uses per week—the training and monitoring burden for reusable protocol compliance wipes out the savings. One 2023 internal review found reusable protocol failures running at 22% in smaller wards, mostly due to inconsistent staff adherence. The defect rate, not the unit price, drove the total cost up.

So the built-in advantage isn't universal. It's volume-dependent. Below a certain threshold, the premium doesn't amortize, and you're paying for a feature that never earns back its keep.

Dimension 2: Operational Efficiency — Steps Removed vs. Steps Added

Every infection control protocol is a series of steps. Built-in design removes steps. Added-on protocols rely on steps being performed correctly, every time, by people who are already busy.

Consider an ultrasound machine. A standard unit requires probe disinfection between patients—typically a multi-step manual process involving wipes, wait time, and documentation. A unit with built-in UV disinfection or single-use probe covers cuts that to one step. We measured this in our Q1 2024 workflow audit: the manual process averaged 4.2 minutes per patient. The built-in process averaged 1.1 minutes. On a 12-patient morning schedule, that's 37 minutes saved per sonographer per day.

But here's the part the brochures leave out: built-in efficiency only works if the device gets used the way it's designed. I've seen sites buy a closed-system Smiths Medical syringe pump and then bypass the closed medication path because "it's faster to load the old way." That's not a device failure—it's an implementation failure. The efficiency gain is real, but it's conditional on behavior.

What I mean is that built-in design shifts the compliance burden from the nurse to the engineer. And engineers, at least in my experience, are more consistent than humans under time pressure. That's the quiet advantage nobody puts in the spec sheet.

Dimension 3: Compliance Consistency — Standardized vs. Variable

This is where the comparison gets uncomfortable for the added-on approach.

Built-in infection control design is standardized. The device either has the feature or it doesn't. It either works or it fails—and when it fails, it fails visibly. Added-on protocols, by contrast, fail silently. A missed disinfection step doesn't announce itself. You find out weeks later when an infection rate ticks up or an audit turns up a gap you can't explain.

I ran a blind audit across two of our partner facilities in 2024. Facility A used devices with built-in infection control features; Facility B relied on manual protocols with the same underlying device category. Facility A's protocol adherence rate was 98.2%, measured by device logs. Facility B's was 71.4%, measured by direct observation. Same training curriculum. Same staffing ratios. The difference was whether the system enforced the step or a person had to remember it.

Now, a caveat: Facility A was also newer, with a more stable nursing roster. I can't isolate device design as the only variable. But 27 points of adherence gap is hard to explain away. And the direction matches what I've seen across 6 years of supplier audits. I can only speak to domestic facilities—if you're dealing with international operations, there are probably factors I'm not aware of.

Here's where the Smiths Medical Minnesota-based support team entered the picture. During our Q1 2024 supplier audit, their clinical support group ran a protocol verification session with our staff—not a sales pitch, an actual walkthrough of the compliance documentation. That kind of support doesn't show up in a spec sheet, but it affects the consistency number. At least, it did for us.

Selection Guidance: When to Choose Which

Neither. That's the short answer. The right approach depends on conditions.

Choose built-in design when:

  • Your volume exceeds the threshold where labor savings offset the price premium—for us, roughly 80 units in active use.
  • Your staffing is variable or turnover is high.
  • Your audit burden is heavy, because built-in design generates cleaner documentation.
  • You're standardizing across multiple sites and need consistent numbers.

Choose added-on protocols when:

  • Volume is low enough that the per-unit premium doesn't amortize.
  • You have stable, well-trained staff with low turnover and strong adherence history.
  • The device category lacks built-in options—some still do.
  • Capital budget is the binding constraint, not operating budget.

One more thing: don't trust the marketing claim. Per FTC guidelines (ftc.gov), advertising claims must be truthful and substantiated. But "substantiated" doesn't mean "applicable to your setting." A manufacturer can have a valid study showing a 40% reduction in contamination risk and still have a product that performs differently in your workflow. Ask for the protocol, not the brochure. I've rejected 12% of submissions in 2024 for exactly that reason—claims without site-specific evidence.

Wait—I should walk that back slightly. Rejecting 12% sounds dramatic. The real number includes submissions that were incomplete rather than false. Maybe 4% were substantively misleading. The rest were paperwork gaps. Still enough to matter, not enough to sound like a crisis. A lesson learned the hard way about how numbers land.

That's the comparison. Built-in design is more efficient and more consistent—when the volume and staffing conditions support it. Added-on protocols still work in stable, low-volume settings. The mistake is assuming one approach fits every procurement scenario. It doesn't. And the spec sheet I maintain now says so, in writing, with a footnote I add every quarter.

Request supporting documents View related products
Mikkel Sorensen

Mikkel Sorensen

Mikkel Sorensen is a rehabilitation and patient-handling equipment analyst covering power wheelchairs, manual wheelchairs, hospital beds, patient lifts, transfer aids, mobility scooters, prosthetic components, and orthotic systems. He references the ISO 7176 series and IEC 80601-2-52 while assessing static stability, braking, fatigue strength, turning space, safe working load, entrapment zones, battery range, actuator duty, and postural adjustability. His work assists rehabilitation clinicians, care facilities, biomedical teams, and buyers with fit, transfer safety, accessibility, maintenance, durability, and fleet planning.

PreviousA quality and regulatory affairs manager on why ENT endoscopes, fundus cameras, and Holter monitors keep underperforming in clinical practice despite passing procurement review—and what actually closes the gap between spec sheets and clinical reality. NextAn office administrator's guide to comparing fluoroscopy systems, CT scan machines, ultrasound units, dental imaging, and IOL options—and why the cheapest quote is rarely the whole story.

Discuss this article